Does TADALAFIL Cause Hepatic cirrhosis? 73 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Hepatic cirrhosis have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.2% of all adverse event reports for TADALAFIL.
73
Reports of Hepatic cirrhosis with TADALAFIL
0.2%
of all TADALAFIL reports
33
Deaths
34
Hospitalizations
How Dangerous Is Hepatic cirrhosis From TADALAFIL?
Of the 73 reports, 33 (45.2%) resulted in death, 34 (46.6%) required hospitalization, and 6 (8.2%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
Which TADALAFIL Alternatives Have Lower Hepatic cirrhosis Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR